Skip to main content

US ClosedU.S. Closed

EWTX: Edgewise Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Edgewise Therapeutics, Inc. is a biopharmaceutical firm dedicated to developing small-molecule treatments for a range of musculoskeletal disorders.

52W Range

84thpctl

Volume

0.53×avg

Market Cap

4.60BUSD

P/E Ratio

-23.1TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

Edgewise Therapeutics, Inc.

EWTXNASDAQ Global Select·USD·Closed

Edgewise Therapeutics, Inc.

EWTXNASDAQ·USD·Closed

$42.76

−3.24%

$42.76

−$1.43 (3.24%)

52W Range

84thpctl

Volume

0.53×avg

Mkt Cap

4.60BUSD

P/E

-23.1TTM

Div Yield

–ann